Detalles de la búsqueda
1.
Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C et al.
Ann Rheum Dis
; 82(6): e131, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33692020
2.
Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al.
Ann Rheum Dis
; 81(8): e135, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660976
3.
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases.
Ann Rheum Dis
; 81(2): 289-291, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34489304
4.
Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al.
Ann Rheum Dis
; 80(5): e64, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32546600
5.
Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis.
Ann Rheum Dis
; 79(4): e40, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30700422
Resultados
1 -
5
de 5
1
Próxima >
>>